Cancer Gene Therapy Market Report 2026
Download Free Sample Buy Now
Cancer Gene Therapy Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Cancer Gene Therapy Market Report 2026

Global Outlook – By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer), By Indication (Large B-Cell Lymphoma, Multiple Myeloma, Acute Lymphoblastic Leukemia (ALL), Melanoma (lesions), Other Indications), By Vector Type (Lentivirus, RetroVirus And Gamma RetroVirus, Adeno-Associated Virus (AAV), Modified Herpes Simplex Virus, Adenovirus, Other Vector Types), By End-User (Hospitals, Research Institutes, Biopharma Companies, Cell Therapy Manufacturing Centers, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Cancer Gene Therapy Market Overview

• Cancer Gene Therapy market size has reached to $4.21 billion in 2025

• Expected to grow to $8.9 billion in 2030 at a compound annual growth rate (CAGR) of 16.1%

• Growth Driver: Rising Cancer Incidence Fueling The Growth Of The Market Due To Increasing Life Expectancy

• Market Trend: Breakthrough In Affordable Personalized Cancer Treatment Through Advanced Cell Therapy

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cancer Gene Therapy Market?

Cancer gene therapy is a treatment that uses special genes to help fight cancer. It works by changing or adding genes in a person’s cells to stop the cancer from growing. This can help the body attack the cancer more effectively. The goal is to treat the disease in a more targeted and less harmful way than traditional methods.

The main types of cancer gene therapies include gene-induced immunotherapy, oncolytic virotherapy, and gene transfer. Gene-induced immunotherapy uses genes to enhance the body's immune system so it can better identify and eliminate cancer cells. It is used for various indications such as large B-cell lymphoma, multiple myeloma, acute lymphoblastic leukemia (ALL), melanoma, and others, and uses different vector types including lentivirus, retrovirus and gamma retrovirus, adeno-associated virus (AAV), modified herpes simplex virus, adenovirus, and others. It is used by several end-users, including hospitals, research institutes, biopharma companies, diagnostic centers, and others.

Cancer Gene Therapy Market Global Report 2026 Market Report bar graph

What Is The Cancer Gene Therapy Market Size and Share 2026?

The cancer gene therapy market size has grown rapidly in recent years. It will grow from $4.21 billion in 2025 to $4.9 billion in 2026 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to advancements in molecular oncology research, expansion of clinical trials in gene therapy, increasing investment in biopharmaceutical R&D, regulatory approvals of early gene therapies, improved vector manufacturing capabilities.

What Is The Cancer Gene Therapy Market Growth Forecast?

The cancer gene therapy market size is expected to see rapid growth in the next few years. It will grow to $8.9 billion in 2030 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to increasing demand for personalized cancer treatments, rising investment in cell and gene therapy manufacturing, expansion of next-generation viral vectors, growing focus on combination oncology therapies, increasing adoption of precision oncology approaches. Major trends in the forecast period include increasing development of targeted gene therapy platforms, rising adoption of CAR-T and TCR therapies, growing focus on viral vector optimization, expansion of personalized cancer gene treatments, enhanced integration of biomarker-guided therapy selection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Cancer Gene Therapy Market Segmentation

1) By Therapy: Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer

2) By Indication: Large B-Cell Lymphoma, Multiple Myeloma, Acute Lymphoblastic Leukemia (ALL), Melanoma (lesions), Other Indications

3) By Vector Type: Lentivirus, RetroVirus And Gamma RetroVirus, Adeno-Associated Virus (AAV), Modified Herpes Simplex Virus, Adenovirus, Other Vector Types

4) By End-User: Hospitals, Research Institutes, Biopharma Companies, Cell Therapy Manufacturing Centers, Other End Users

Subsegments:

1) By Gene Induced Immunotherapy: CAR-T Cell Therapy, TCR (T-Cell Receptor) Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell-Based Gene Therapy, NK Cell Gene Therapy

2) By Oncolytic Virotherapy: Adenoviruses, Herpes Simplex Virus (HSV), Reovirus, Vaccinia Virus, Newcastle Disease Virus (NDV)

3) By Gene Transfer: Viral Gene Transfer, Non-Viral Gene Transfer

What Is The Driver Of The Cancer Gene Therapy Market?

The increasing cancer incidence is expected to propel the growth of the cancer gene therapy market going forward. Cancer is a disease characterized by the uncontrolled multiplication of abnormal cells that can invade and spread to other parts of the body, arising in various tissues and organs and classified based on the cell or tissue type from which it originates. Cancer cases are increasing due to rising life expectancy, as the risk of developing cancer grows with age. Cancer gene therapy treats cancer by modifying or replacing faulty genes to stop cancer cell growth or enhance the immune system's ability to destroy them. For instance, in August 2024, Macmillan Cancer Support, a UK-based organization, reported that more than 3 million people in the UK are living with cancer. This figure is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing cancer incidence is driving the growth of the cancer gene therapy industry.

Key Players In The Global Cancer Gene Therapy Market

Major companies operating in the cancer gene therapy market are Bristol Myers Company, Novartis AG, GSK plc., Gilead Sciences Inc., Amgen Inc., Orchard Therapeutics Plc, AGC Biologics, Adaptimmune Limited, Sibiono, Elevate Bio Inc., Bluebird Bio Inc., Uniqure N.V., Shanghai Sunway Biotech Co. Ltd., Anges Inc., Gensight Biologics, Genelux Corporation, Cellectis, Abeona Therapeutics Inc., Kite Pharma Inc., Janssen Biotech Inc., Mustang Bio Inc., Intellia Therapeutics Inc., CRISPR Therapeutics AG, Caribou Biosciences Inc.

Global Cancer Gene Therapy Market Trends and Insights

Major companies operating in the cancer gene therapy market are focusing on developing advanced therapies, such as CAR-T cell therapy, to enhance treatment precision, improve patient outcomes, and target cancer cells more effectively while minimizing damage to healthy tissues. CAR-T therapy is an advanced immunotherapy where a patient’s immune cells are engineered to better detect and destroy cancer cells by adding special receptors to them. For instance, in April 2024, ImmunoACT, an India-based biotechnology company, launched NexCAR19 (actalycabtagene autoleucel), the country's first indigenously developed CAR-T cell therapy for cancer. Specifically designed to treat B-cell lymphomas and leukemias, NexCAR19 works by reprogramming a patient's own T cells to identify and destroy cancer cells. Based on advanced chimeric antigen receptor (CAR) technology, the therapy is locally manufactured, making it more affordable and accessible than imported alternatives. This launch marks a major milestone in India's entry into the global cancer gene therapy space, highlighting significant progress in domestic innovation and personalized cancer treatment.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Cancer Gene Therapy Market?

In May 2025, AstraZeneca plc, a UK-based biopharmaceutical company, acquired EsoBiotec B.V. for an undisclosed amount. With this acquisition, it aims to strengthen its cell therapy capabilities, accelerating its ambition to develop next-generation treatments in oncology and immune-mediated diseases. EsoBiotec B.V. is a Switzerland-based biotechnology company that specializes in cancer gene therapies.

Regional Outlook

North America was the largest region in the cancer gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cancer Gene Therapy Market?

The cancer gene therapy market consists of revenues earned by entities by providing services such as gene delivery services, clinical trial services, gene editing, and cell-based therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The cancer gene therapy market also includes sales of gene therapy drugs, viral vectors, non-viral delivery systems, and plasmids. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cancer Gene Therapy Market Report 2026?

The cancer gene therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cancer gene therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Cancer Gene Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.9 billion
Revenue Forecast In 2035 $8.9 billion
Growth Rate CAGR of 16.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Therapy, Indication, Vector Type, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Bristol Myers Company, Novartis AG, GSK plc., Gilead Sciences Inc., Amgen Inc., Orchard Therapeutics Plc, AGC Biologics, Adaptimmune Limited, Sibiono, Elevate Bio Inc., Bluebird Bio Inc., Uniqure N.V., Shanghai Sunway Biotech Co. Ltd., Anges Inc., Gensight Biologics, Genelux Corporation, Cellectis, Abeona Therapeutics Inc., Kite Pharma Inc., Janssen Biotech Inc., Mustang Bio Inc., Intellia Therapeutics Inc., CRISPR Therapeutics AG, Caribou Biosciences Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cancer Gene Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cancer Gene Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cancer Gene Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cancer Gene Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Development Of Targeted Gene Therapy Platforms

4.2.2 Rising Adoption Of Car-T And Tcr Therapies

4.2.3 Growing Focus On Viral Vector Optimization

4.2.4 Expansion Of Personalized Cancer Gene Treatments

4.2.5 Enhanced Integration Of Biomarker-Guided Therapy Selection

5. Cancer Gene Therapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Research Institutes

5.3 Biopharma Companies

5.4 Diagnostic Centers

5.5 Clinical Research Organizations

6. Cancer Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cancer Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cancer Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cancer Gene Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cancer Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cancer Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cancer Gene Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cancer Gene Therapy Market Segmentation

9.1. Global Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer

9.2. Global Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Large B-Cell Lymphoma, Multiple Myeloma, Acute Lymphoblastic Leukemia (ALL), Melanoma (lesions), Other Indications

9.3. Global Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lentivirus, RetroVirus And Gamma RetroVirus, Adeno-Associated Virus (AAV), Modified Herpes Simplex Virus, Adenovirus, Other Vector Types

9.4. Global Cancer Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Research Institutes, Biopharma Companies, Cell Therapy Manufacturing Centers, Other End Users

9.5. Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Induced Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CAR-T Cell Therapy, TCR (T-Cell Receptor) Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell-Based Gene Therapy, NK Cell Gene Therapy

9.6. Global Cancer Gene Therapy Market, Sub-Segmentation Of Oncolytic Virotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adenoviruses, Herpes Simplex Virus (HSV), Reovirus, Vaccinia Virus, Newcastle Disease Virus (NDV)

9.7. Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Transfer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Gene Transfer, Non-Viral Gene Transfer

10. Cancer Gene Therapy Market Regional And Country Analysis

10.1. Global Cancer Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cancer Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cancer Gene Therapy Market

11.1. Asia-Pacific Cancer Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cancer Gene Therapy Market

12.1. China Cancer Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cancer Gene Therapy Market

13.1. India Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cancer Gene Therapy Market

14.1. Japan Cancer Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cancer Gene Therapy Market

15.1. Australia Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cancer Gene Therapy Market

16.1. Indonesia Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cancer Gene Therapy Market

17.1. South Korea Cancer Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cancer Gene Therapy Market

18.1. Taiwan Cancer Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cancer Gene Therapy Market

19.1. South East Asia Cancer Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cancer Gene Therapy Market

20.1. Western Europe Cancer Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cancer Gene Therapy Market

21.1. UK Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cancer Gene Therapy Market

22.1. Germany Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cancer Gene Therapy Market

23.1. France Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cancer Gene Therapy Market

24.1. Italy Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cancer Gene Therapy Market

25.1. Spain Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cancer Gene Therapy Market

26.1. Eastern Europe Cancer Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cancer Gene Therapy Market

27.1. Russia Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cancer Gene Therapy Market

28.1. North America Cancer Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cancer Gene Therapy Market

29.1. USA Cancer Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cancer Gene Therapy Market

30.1. Canada Cancer Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cancer Gene Therapy Market

31.1. South America Cancer Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cancer Gene Therapy Market

32.1. Brazil Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cancer Gene Therapy Market

33.1. Middle East Cancer Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cancer Gene Therapy Market

34.1. Africa Cancer Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Cancer Gene Therapy Market, Segmentation By Therapy, Segmentation By Indication, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cancer Gene Therapy Market Regulatory and Investment Landscape

36. Cancer Gene Therapy Market Competitive Landscape And Company Profiles

36.1. Cancer Gene Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cancer Gene Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cancer Gene Therapy Market Company Profiles

36.3.1. Bristol Myers Company Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GSK plc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Cancer Gene Therapy Market Other Major And Innovative Companies

Orchard Therapeutics Plc, AGC Biologics, Adaptimmune Limited, Sibiono, Elevate Bio Inc., Bluebird Bio Inc., Uniqure N.V., Shanghai Sunway Biotech Co. Ltd., Anges Inc., Gensight Biologics, Genelux Corporation, Cellectis, Abeona Therapeutics Inc., Kite Pharma Inc., Janssen Biotech Inc.

38. Global Cancer Gene Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cancer Gene Therapy Market

40. Cancer Gene Therapy Market High Potential Countries, Segments and Strategies

40.1 Cancer Gene Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Cancer Gene Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Cancer Gene Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Cancer Gene Therapy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Cancer Gene Therapy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Cancer Gene Therapy Market, Supply Chain Analysis
  • Table 4: Global Cancer Gene Therapy Market, Major Raw Material Providers
  • Table 5: Global Cancer Gene Therapy Market, Major Resource Providers
  • Table 6: Global Cancer Gene Therapy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Cancer Gene Therapy Market, Major Distributors And Channel Partners
  • Table 8: Global Cancer Gene Therapy Market, Key Technologies & Future Trends
  • Table 9: Global Cancer Gene Therapy Market, Major Trends
  • Table 10: Global Cancer Gene Therapy Market, Major End Users
  • Table 11: Global Cancer Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Cancer Gene Therapy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Cancer Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Cancer Gene Therapy Market - TAM, US$ Billion, 2025
  • Table 15: Global Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Cancer Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Induced Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Cancer Gene Therapy Market, Sub-Segmentation Of Oncolytic Virotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Transfer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Cancer Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Cancer Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Cancer Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Cancer Gene Therapy Market - Company Scoring Matrix
  • Table 98: Bristol Myers Company Financial Performance
  • Table 99: Novartis AG Financial Performance
  • Table 100: GSK plc. Financial Performance
  • Table 101: Gilead Sciences Inc. Financial Performance
  • Table 102: Amgen Inc. Financial Performance
  • Table 103: Global Cancer Gene Therapy Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Cancer Gene Therapy Market, Competitive Dashboard
  • Table 105: Global Cancer Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Cancer Gene Therapy Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030
  • Table 107: Global, Cancer Gene Therapy Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 108: Global, Cancer Gene Therapy Market Size Gain ($ Billion), Segmentation By Vector Type, 2025 – 2030

List Of Figures

    Figure 1: Global Cancer Gene Therapy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Cancer Gene Therapy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Cancer Gene Therapy Market, Supply Chain Analysis
  • Figure 4: Global Cancer Gene Therapy Market, Major Raw Material Providers
  • Figure 5: Global Cancer Gene Therapy Market, Major Resource Providers
  • Figure 6: Global Cancer Gene Therapy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Cancer Gene Therapy Market, Major Distributors And Channel Partners
  • Figure 8: Global Cancer Gene Therapy Market, Key Technologies & Future Trends
  • Figure 9: Global Cancer Gene Therapy Market, Major Trends
  • Figure 10: Global Cancer Gene Therapy Market, Major End Users
  • Figure 11: Global Cancer Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Cancer Gene Therapy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Cancer Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Cancer Gene Therapy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Cancer Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Induced Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Cancer Gene Therapy Market, Sub-Segmentation Of Oncolytic Virotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Transfer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Cancer Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Cancer Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Cancer Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Cancer Gene Therapy Market - Company Scoring Matrix
  • Figure 98: Bristol Myers Company Financial Performance
  • Figure 99: Novartis AG Financial Performance
  • Figure 100: GSK plc. Financial Performance
  • Figure 101: Gilead Sciences Inc. Financial Performance
  • Figure 102: Amgen Inc. Financial Performance
  • Figure 103: Global Cancer Gene Therapy Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Cancer Gene Therapy Market, Competitive Dashboard
  • Figure 105: Global Cancer Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Cancer Gene Therapy Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030
  • Figure 107: Global, Cancer Gene Therapy Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 108: Global, Cancer Gene Therapy Market Size Gain ($ Billion), Segmentation By Vector Type, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Commercial Fan And Air Purification Equipment Market - By Type (Air Purification Equipment, Attic And Exhaust Fan), By Range (Less Than 200 Square Ft, 200 - 400 Square Ft, More Than 400 Square Ft), And By Region, Opportu...

Commercial Fan And Air Purification Equipment Market - By Type (Air Purification Equipment, Attic And Exhaust Fan), By Range (Less Than 200 Square Ft, 200 - 400 Square Ft, More Than 400 Square Ft), And By Region, Opportu...

Farm Equipment Rental Market Report 2026 - Global Outlook – By Equipment Type (Tractors, Harvesters, Sprayers, Balers, Other Equipment Types), By Power Output (<30 HP, 31-70 HP, 71-130 HP, 131-250 HP, <250 HP), By Drive ...

Consumer Electronics And Appliances Rental Market Report 2026 - Global Outlook – By Type ( Home Appliances, Refrigerator, Air Cooler, TV (Television), Washing Machine, Others), By Distribution Channel ( Online, Offline),...

Household Type Fans Market Report 2026 - Global Outlook – By Type Of Product ( Ceiling Fans, Table, Pedestal And Wall Fans, Exhaust Fans And Others), By Type of Current ( AC Residential Fans, DC Residential Fans), By App...

Dental Consumables Market Report 2026 - Global Outlook – By Product (Dental Implants, Dental Prosthetics, Endodontics, Orthodontics, Periodontics, Other Products), By Material (Metals, Polymers, Ceramics, Biomaterials), ...

HVAC And Commercial And Industrial Refrigeration Equipment Market Report 2026 - Global Outlook – By Type (HVAC Equipment, Commercial And Industrial Refrigeration Equipment ), By Capacity (Small, Medium, Large), By Applic...

Dental Services Market 2022 – By Type (General Dentistry, Oral Surgery, Orthodontics, Prosthodontics), By Type Of Procedure (Cosmetic Dentistry, Non-Cosmetic Dentistry), By End-User (Gender) (Male, Female), By Type Of Ex...

Frequently Asked Questions

The Cancer Gene Therapy market was valued at $4.21 billion in 2025, increased to $4.9 billion in 2026, and is projected to reach $8.9 billion by 2030.

The global Cancer Gene Therapy market is expected to grow at a CAGR of 16.1% from 2026 to 2035 to reach $8.9 billion by 2035.

Some Key Players in the Cancer Gene Therapy market Include, Bristol Myers Company, Novartis AG, GSK plc., Gilead Sciences Inc., Amgen Inc., Orchard Therapeutics Plc, AGC Biologics, Adaptimmune Limited, Sibiono, Elevate Bio Inc., Bluebird Bio Inc., Uniqure N.V., Shanghai Sunway Biotech Co. Ltd., Anges Inc., Gensight Biologics, Genelux Corporation, Cellectis, Abeona Therapeutics Inc., Kite Pharma Inc., Janssen Biotech Inc., Mustang Bio Inc., Intellia Therapeutics Inc., CRISPR Therapeutics AG, Caribou Biosciences Inc. .

Major trend in this market includes: Breakthrough In Affordable Personalized Cancer Treatment Through Advanced Cell Therapy. For further insights on this market. request a sample here

North America was the largest region in the cancer gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us